FindTrial
Sign In

The role of CTRP9 in insulin resistance in patients with gestational diabetes mellitus and its effect on disease outcome

The role of CTRP9 in insulin resistance in patients with gestational diabetes mellitus and its effect on disease outcome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060711
Enrollment
Unknown
Registered
2022-06-09
Start date
2019-11-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

GDM group:None
Control group :None

Sponsors

Huai'an First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Pregnant women with a diagnosis of gestational diabetes mellitus.

Exclusion criteria

Exclusion criteria: 1.Aged 40 years; 2.Smoking or drinking; 3.History of abortion; 4.Pregestational diabetes mellitus; 5.Multifetal pregnancy; 6.Immunosuppressive treatment; 7.Pregnancy-induced hypertension and/or preeclampsia; 8.Acute and chronic systemic inflammation.

Design outcomes

Primary

MeasureTime frame
C1q/TNF Related Protein 9;HOMA-Insulin Resistance index;—

Countries

China

Contacts

Public ContactMin Shi

Huai'an First People's Hospital

smjcl@163.com+86 15861759298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026